ストックスクリーナーアプリを入手
70.00
1.32%
0.91
アフターアワーズ：
69.38
-0.62
-0.89%
前日終値:
$69.09
開ける：
$68.23
24時間の取引高:
955.42K
Relative Volume:
1.02
時価総額：
$4.78B
収益：
-
当期純損益:
$-146.66M
株価収益率:
-25.42
EPS:
-2.7541
ネットキャッシュフロー:
$-133.21M
1週間 パフォーマンス:
+2.35%
1か月 パフォーマンス:
-3.29%
6か月 パフォーマンス:
+85.23%
1年 パフォーマンス:
+129.28%
1日の値動き範囲:
$66.00
$70.30
1週間の範囲:
$66.00
$73.71
52週間の値動き範囲:
$26.20
$84.56
Apogee Therapeutics Inc Stock (APGE) Company Profile
Compare APGE vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
70.00 | 4.72B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.83 | 121.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.67 | 81.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
766.92 | 47.74B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.92 | 43.93B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.67B | 4.98B | 69.60M | 525.67M | 0.5198 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-22 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-07 | 開始されました | Wolfe Research | Peer Perform |
| 2025-12-17 | 開始されました | Stephens | Overweight |
| 2025-12-10 | 開始されました | Deutsche Bank | Buy |
| 2025-11-03 | 開始されました | Craig Hallum | Buy |
| 2025-10-21 | 開始されました | Mizuho | Outperform |
| 2025-09-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-07-07 | 繰り返されました | BTIG Research | Buy |
| 2025-03-13 | 開始されました | Citigroup | Buy |
| 2024-11-25 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-10 | 開始されました | BofA Securities | Buy |
| 2023-12-20 | 開始されました | BTIG Research | Buy |
| 2023-08-08 | 開始されました | Guggenheim | Buy |
| 2023-08-08 | 開始されました | Jefferies | Buy |
| 2023-08-08 | 開始されました | Stifel | Buy |
| 2023-08-08 | 開始されました | TD Cowen | Outperform |
| 2023-08-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Apogee Therapeutics Inc (APGE) 最新ニュース
Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million - AOL.com
Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million - The Motley Fool
Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Promising Biotech with Nearly 50% Upside Potential - DirectorsTalk Interviews
Apogee Therapeutics to Participate in Upcoming March Conferences - The Manila Times
Apogee Therapeutics (APGE) Expected to Announce Earnings on Monday - Defense World
Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction - Yahoo Finance
Aberdeen Group plc Takes Position in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics Inc. (NASDAQ:APGE) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
What is Apogee Therapeutics Inc. s 5 year growth outlookJuly 2025 Rallies & Stock Market Timing Techniques - mfd.ru
Apogee Therapeutics Rings the Closing Bell - Nasdaq
End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations - Finviz
Technical Reactions to APGE Trends in Macro Strategies - Stock Traders Daily
Is Apogee Therapeutics (APGE) Now Defined by Its IL-13/OX40L Positioning Against Sanofi? - Yahoo Finance
Here is Why Apogee Therapeutics (APGE) Appears Attractive - Yahoo Finance
CEO Moves: What is Apogee Therapeutics Inc. s 5 year growth outlook2025 Market WrapUp & Weekly Top Gainers Trade List - mfd.ru
Michael Thomas Henderson Sells 20,000 Shares of Apogee Therapeutics (NASDAQ:APGE) Stock - MarketBeat
CEO Michael Henderson Sells 20,000 Shares of Apogee Therapeutics Inc - GuruFocus
Apogee Therapeutics CEO Sells 20,000 Shares - TradingView
What’s the beta of Apogee Therapeutics Inc. stockTrade Volume Report & Technical Pattern Alert System - mfd.ru
Apogee Therapeutics touts quarterly-to-biannual AD dosing shift, expands asthma ambitions at conference - MarketBeat
Page not foundAirwhon - MarketBeat
APGE: Quarterly dosing, rapid itch relief, and strong safety set up a 2029 launch to challenge market leaders - TradingView
Aug Breakouts: Can Apogee Therapeutics Inc. stock outperform in a bear marketJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - mfd.ru
Candriam S.C.A. Invests $5.01 Million in Apogee Therapeutics Inc. $APGE - MarketBeat
Can Apogee Therapeutics Inc. sustain earnings growth2025 Year in Review & Capital Efficient Trade Techniques - mfd.ru
Apogee Therapeutics stock hits 52-week high at 62.24 USD By Investing.com - Investing.com Australia
Apogee Therapeutics stock hits 52-week high at 62.24 USD - Investing.com
Smart Money: Should I set a stop loss on Lichen International LimitedEarnings Growth Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
Trading the Move, Not the Narrative: (APGE) Edition - Stock Traders Daily
Portfolio Update: What is Apogee Therapeutics Incs 5 year growth outlook2025 Sector Review & Fast Moving Trade Plans - baoquankhu1.vn
Apogee Therapeutics to Participate at the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Insider Selling: Apogee Therapeutics (NASDAQ:APGE) Insider Sells 5,500 Shares of Stock - MarketBeat
Insider Sell: Jane Henderson Sells 2,000 Shares of Apogee Therap - GuruFocus
Apogee Therapeutics CMO sells $361,860 in shares By Investing.com - Investing.com Nigeria
Apogee Therapeutics CMO sells $361,860 in shares - Investing.com
Apogee Therapeutics, Inc. (APGE) Stock Analysis: A 58.9% Potential Upside for Investors in the Biotech Sector - DirectorsTalk Interviews
Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns By Investing.com - Investing.com Canada
Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns - Investing.com
What drives Apogee Therapeutics Inc.’s stock priceEarnings Overview Summary & Low Risk Entry Point Tips - mfd.ru
Fairmount Funds Management LLC Increases Stake in Apogee Therape - GuruFocus
Aug Gainers: Can Apogee Therapeutics Inc stock outperform in a bear marketWeekly Stock Recap & Long-Term Growth Stock Strategies - baoquankhu1.vn
Exane Asset Management Invests $2.05 Million in Apogee Therapeutics Inc. $APGE - MarketBeat
Apogee Therapeutics Inc (APGE) 財務データ
収益
当期純利益
現金流量
EPS
1.18%
0.45%
大文字化:
|
ボリューム (24 時間):